Moreover, the observation that Gpr132 expression is significantly increased in the majority of human breast cancers (Figure 4B) suggests that Gpr132 may serve as a useful marker for breast cancer prognosis, similar to the 21 genes typically examined in the commercially available Oncotype Dx panel. The gene discussed is GPR132; the disease is breast carcinoma.